ENOVIS CORP (ENOV) Stock Price & Overview
NYSE:ENOV • US1940141062
The current stock price of ENOV is 24.66 USD. Today ENOV is up by 0.61%. In the past month the price increased by 9.16%. In the past year, price decreased by -33.44%.
ENOV Key Statistics
- Market Cap
- 1.412B
- P/E
- 7.47
- Fwd P/E
- 6.84
- EPS (TTM)
- 3.30
- Dividend Yield
- N/A
ENOV Stock Performance
ENOV Stock Chart
ENOV Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ENOV. When comparing the yearly performance of all stocks, ENOV is a bad performer in the overall market: 84.76% of all stocks are doing better.
ENOV Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to ENOV. ENOV has a medium profitability rating, but doesn't score so well on its financial health evaluation.
ENOV Earnings
On February 26, 2026 ENOV reported an EPS of 0.95 and a revenue of 575.76M. The company beat EPS expectations (13.32% surprise) and missed revenue expectations (-3.32% surprise).
ENOV Forecast & Estimates
18 analysts have analysed ENOV and the average price target is 46.36 USD. This implies a price increase of 88.01% is expected in the next year compared to the current price of 24.66.
For the next year, analysts expect an EPS growth of 9.27% and a revenue growth 4.04% for ENOV
ENOV Groups
Sector & Classification
ENOV Financial Highlights
Over the last trailing twelve months ENOV reported a non-GAAP Earnings per Share(EPS) of 3.3. The EPS increased by 16.61% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -30.89% | ||
| ROE | -79.51% | ||
| Debt/Equity | 0.85 |
ENOV Ownership
ENOV Latest News, Press Relases and Analysis
ENOV Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.61 | 190.38B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.29 | 174.071B | ||
| SYK | STRYKER CORP | 24.19 | 139.513B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.56 | 105.876B | ||
| IDXX | IDEXX LABORATORIES INC | 41.18 | 48.442B | ||
| BDX | BECTON DICKINSON AND CO | 12.14 | 47.586B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.34 | 47.376B | ||
| RMD | RESMED INC | 20.6 | 36.838B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.63 | 33.849B | ||
| DXCM | DEXCOM INC | 27.04 | 26.209B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11 | 18.413B | ||
| HOLX | HOLOGIC INC | 15.4 | 16.908B | ||
| PODD | INSULET CORP | 37.18 | 16.686B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ENOV
Company Profile
Enovis Corp. operates as a medical technology growth company. The company is headquartered in Wilmington, Delaware and currently employs 7,802 full-time employees. The company went IPO on 2008-05-08. The company is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. The company operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company also operates a Enovis Growth eXcellence business system (EGX).
Company Info
ENOVIS CORP
2711 Centerville Road, Suite 400
Wilmington DELAWARE US
Employees: 7802
Phone: 13022529160
ENOVIS CORP / ENOV FAQ
What does ENOVIS CORP do?
Enovis Corp. operates as a medical technology growth company. The company is headquartered in Wilmington, Delaware and currently employs 7,802 full-time employees. The company went IPO on 2008-05-08. The company is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. The company operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company also operates a Enovis Growth eXcellence business system (EGX).
What is the stock price of ENOVIS CORP today?
The current stock price of ENOV is 24.66 USD. The price increased by 0.61% in the last trading session.
What is the dividend status of ENOVIS CORP?
ENOV does not pay a dividend.
What is the ChartMill rating of ENOVIS CORP stock?
ENOV has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Can you provide the sector and industry classification for ENOVIS CORP?
ENOVIS CORP (ENOV) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Can you provide the growth outlook for ENOVIS CORP?
The Revenue of ENOVIS CORP (ENOV) is expected to grow by 4.04% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the next earnings date for ENOV stock?
ENOVIS CORP (ENOV) will report earnings on 2026-05-06, before the market open.